ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies
ImpriMed has raised $23.0M in total funding. The most recent round was Series A. The last funding was announced in November 2023.
ImpriMed's investors include Plug and Play, Pear VC, Draper Associates, SBVA, Mayo Clinic.
ImpriMed is headquartered in Mountain View, United States.
ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies
ImpriMed is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImpriMed — Funding & Investors." VCBacked, November 6, 2023, https://www.vcbacked.co/company/imprimed. Accessed July 19, 2026.
VCBacked. (2023). ImpriMed — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/imprimed
{{cite web |title=ImpriMed — Funding & Investors |url=https://www.vcbacked.co/company/imprimed |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated